- A Canadian cruise passenger has tested presumptive positive for the rare Andes hantavirus, which can spread between people.
- The Andes hantavirus is typically found in South America, but this case marks one of the few documented instances outside the region.
- Public health teams are scrambling to trace contacts and prevent a wider outbreak among the 150+ passengers and crew on the MV Hondius.
- The Andes hantavirus causes hantavirus pulmonary syndrome (HPS), a severe respiratory illness with a fatality rate of up to 40%.
- The risk of transmission is elevated in close quarters like cruise ships, where people are in close contact with each other.
Is a rare and potentially deadly virus spreading on a luxury Antarctic cruise? That’s the urgent question facing Canadian and international health authorities after a passenger aboard the MV Hondius tested presumptive positive for the Andes hantavirus. Unlike most hantaviruses, which spread only from rodents to humans, the Andes strain has shown the ability to transmit between people—a rare and alarming trait that elevates the risk in close quarters like cruise ships. With over 150 passengers and crew potentially exposed during the expedition, public health teams are scrambling to trace contacts, issue guidance, and prevent a wider outbreak. The case marks one of the few documented instances of Andes hantavirus outside South America and has reignited concerns about zoonotic diseases in remote travel settings.
What Is the Andes Hantavirus and How Did It Reach Canada?
The Andes hantavirus, a subtype of hantavirus found primarily in Argentina and Chile, causes hantavirus pulmonary syndrome (HPS)—a severe respiratory illness with a fatality rate of up to 40%. It is typically transmitted through inhalation of aerosolized particles from infected rodent droppings or urine, but unlike other hantaviruses, it can also spread from person to person, especially through close contact with respiratory secretions. Public health officials believe the Canadian passenger may have contracted the virus during prior travel in rural southern Chile, where the virus is endemic. After boarding the MV Hondius for an Antarctic expedition, the individual developed flu-like symptoms, prompting quarantine and testing. The “presumptive positive” result, confirmed by Canada’s National Microbiology Laboratory, means the virus was detected but awaits final sequencing for full confirmation. The passenger has been isolated, and health agencies are now assessing exposure timelines.
What Evidence Supports Human-to-Human Transmission?
Multiple studies have documented person-to-person spread of the Andes hantavirus, particularly during outbreaks in Argentina. A 2019 study published in The Lancet Infectious Diseases analyzed a cluster in Epuyén, Argentina, where 27 cases occurred, and found strong evidence of secondary and tertiary transmission among family members and healthcare workers. The virus’s ability to spread via respiratory droplets makes cruise ships, with shared cabins, dining areas, and limited ventilation, high-risk environments. The World Health Organization (WHO) has noted that while most hantaviruses do not transmit between people, Andes virus is an exception requiring strict infection control. Canadian officials are now using this data to model potential exposure pathways on the MV Hondius, focusing on close contacts during the passenger’s symptomatic period.
Are Health Officials Overreacting to a Rare Virus?
Some experts caution against alarm, noting that Andes hantavirus remains extremely rare and that person-to-person transmission requires prolonged, close contact. Dr. Allison McGeer, an infectious disease specialist at Mount Sinai Hospital in Toronto, stated, “While this case is concerning, we’ve seen no evidence of widespread transmission in similar situations.” Skeptics also point out that the MV Hondius, operated by Oceanwide Expeditions, adheres to strict biosecurity protocols for polar travel, including medical screenings and onboard isolation facilities. Additionally, the incubation period for HPS ranges from one to eight weeks, meaning any secondary cases would likely emerge well after passengers have disembarked. Critics argue that media attention may outpace the actual risk, potentially stigmatizing affected individuals and discouraging essential scientific travel to remote regions. Still, public health agencies emphasize preparedness over complacency.
What Are the Real-World Implications for Travelers and Crew?
The immediate impact is being felt by the 153 passengers and crew members who shared the MV Hondius with the infected individual. Canadian and Dutch authorities (since the ship is flagged in the Netherlands) are coordinating contact tracing, with high-risk individuals advised to self-monitor for fever, muscle aches, and shortness of breath for up to eight weeks. Some passengers have voluntarily quarantined upon return, while others await test kits from regional health departments. The cruise line has issued a statement confirming cooperation with health agencies and enhanced cleaning protocols. Beyond this single voyage, the incident may influence future expedition travel policies, particularly in regions bordering hantavirus-endemic zones. Travel medicine experts suggest revising pre-travel counseling to include zoonotic disease awareness, especially for trips involving rural or cave-based activities in South America.
What This Means For You
If you or someone you know was on the MV Hondius Antarctic cruise between late February and early March, monitor for respiratory symptoms and contact public health authorities immediately if they appear. While the risk of infection remains low, early detection is critical—HPS can progress rapidly from mild flu-like signs to life-threatening respiratory failure. For future travelers, this case underscores the importance of understanding regional disease risks, even on high-end, well-managed expeditions. Always disclose recent travel history to healthcare providers if illness follows international trips.
Could this isolated case signal a broader shift in how we manage infectious diseases in remote, high-density travel settings? And as climate change alters rodent habitats, might hantaviruses expand beyond their traditional ranges? These questions demand ongoing surveillance, international cooperation, and updated public health strategies for the evolving landscape of global travel.
Source: MedicalXpress